医院感染鲍曼不动杆菌的分布及耐药分析  

Clinical Isolation and Antibiotic Resistance of Acinetobacter Baumannii in Nosocomial Infections

作　　者：邱春嫦[1] 肖增璜[1] 曹燕[1] 陈佑明[2] 

机构地区：[1]暨南大学附属第一医院检验科,广州市510630 [2]南方医科大学华瑞医院检验科,广州市510630

出　　处：《中国药房》2008年第26期2039-2040,共2页China Pharmacy

摘　　要：目的：了解鲍曼不动杆菌在医院感染中的流行特征及耐药趋势。方法：对2002～2006年243株院内鲍曼不动杆菌感染的分布及药敏结果进行分析．结果：243株鲍曼不动杆菌标本来源以呼吸道分泌物最多（占69．5％），其对亚胺培南的耐药率最低，5年的耐药率均低于6％，而对部分常用抗菌药物的耐药率有逐年上升趋势，其对环丙沙星的耐药率增幅最大为28．6％～75．7％。结论：鲍曼不动杆菌院内感染率和耐药率呈逐年上升趋势，临床应加强监测。OBJECTIVE： To investigate the epidemiological distribution and the drug resistance of acinetobacter baumannii in nosocomial infections. METHODS： The distribution and drug susceptibility of 243 strains of acinetobacter baumannli in nosocomial infections from 2002 to 2006 were retrospectively analyzed. RESULTS： The acinetobacter baumannii were mainly isolated from respiratory tract secretion samples, representing 69.5%. The resistance of acinetobacter baumannii to imipenem was the lowest, lower than 6% over the 5 years; yet its resistance to common antibiotics increased year-on-year, up 28.6%- 75.7% in its resistance to ciprofloxacin. CONCLUSION： The nosocomial infection rates and antibiotic resistance rates of acinetobacter baumannii were increasing year on year. Surveillance of bacterial resistance must be strengthened in the clinic.

关 键 词：鲍曼不动杆菌 感染 耐药性 

分 类 号：R969.3[医药卫生—药理学]